title: Imatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease.
authors.forename: Roberta
authors.initials: R
authors.lastname: Fedele
authors.forename: Massimo
authors.initials: M
authors.lastname: Martino
authors.forename: Antonella
authors.initials: A
authors.lastname: Dattola
authors.forename: Maria
authors.initials: M
authors.lastname: Cuzzola
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Messina
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Irrera
authors.forename: Pasquale
authors.initials: P
authors.lastname: Iacopino
mesh_terms: D001549:Benzamides; D006086:Graft vs Host Disease / Q000139:chemically induced*; D006801:Humans; D000068877:Imatinib Mesylate; D054066:Leukemia, Large Granular Lymphocytic / Q000150:complications / Q000188:drug therapy*; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate